SARS-CoV-2

Meiyue Dong1, Jazmin M Galvan Achi2, Ruikun Du1,3

  • 1Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, 250355, China.

Cell insight
|February 7, 2024
PubMed
概括

本综述详细介绍了严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) 进入机制和抗病毒抑制剂. 它探讨了强大的SARS-CoV-2进入抑制剂和广泛的冠状病毒药物的未来方向.